Moderna is exploring the potential of mRNA in immuno-oncology across various cancer types

Quoting Moderna on LinkedIn:

“Moderna is exploring the potential of mRNA in immuno-oncology across various cancer types, harnessing the body’s immune system to identify and kill cancer cells.

We believe the adaptability of mRNA technology can be leveraged to create an innovative and diverse portfolio of investigational cancer therapies, including individualized approaches.

Join us at AACR24 in San Diego at booth 441 as we continue to showcase the potential of mRNA technology and the possibility of changing cancer care and improving outcomes for patients.”

Source: Moderna/LinkedIn